Budget impact of fixed duration acalabrutinib in combination with venetoclax in previously untreated chronic lymphocytic leukemia patients in the United States
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Farrukh Awan, Nadine Zawadzki, Anna Teschemaker, Kathy Wojtas, David Satre, Vikram Shetty, Dipen Patel, Fady Fam, Ryan Crowley, Jason Shafrin
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417007118
Cites:
Cited by:
Related to: